白花蛇舌草干预大肠腺瘤的网络药理学研究

鲁仕昱, 林辉. 白花蛇舌草干预大肠腺瘤的网络药理学研究[J]. 中国中西医结合消化杂志, 2021, 29(5): 351-357. doi: 10.3969/j.issn.1671-038X.2021.05.10
引用本文: 鲁仕昱, 林辉. 白花蛇舌草干预大肠腺瘤的网络药理学研究[J]. 中国中西医结合消化杂志, 2021, 29(5): 351-357. doi: 10.3969/j.issn.1671-038X.2021.05.10
LU Shi-yu, LIN Hui. The network pharmacology study of Hedyotis diffusa on colorectal adenoma[J]. Chin J Integr Tradit West Med Dig, 2021, 29(5): 351-357. doi: 10.3969/j.issn.1671-038X.2021.05.10
Citation: LU Shi-yu, LIN Hui. The network pharmacology study of Hedyotis diffusa on colorectal adenoma[J]. Chin J Integr Tradit West Med Dig, 2021, 29(5): 351-357. doi: 10.3969/j.issn.1671-038X.2021.05.10

白花蛇舌草干预大肠腺瘤的网络药理学研究

  • 基金项目:

    上海中医药大学附属普陀医院科研课题计划(No:2017316A)

详细信息
    通讯作者: 林辉,E-mail:niliuh@163.com
  • 中图分类号: R735.3

The network pharmacology study of Hedyotis diffusa on colorectal adenoma

More Information
  • 目的:利用网络药理学探讨白花蛇舌草防治大肠腺瘤的作用靶点、生物过程及相关通路,结合中医学的认识,进一步探讨其干预癌前病变的可行性及潜在机制。方法:在Gene Cards和OMIM数据库获取大肠腺瘤疾病的靶点,中药系统药理学数据库(TCMSP)中检索白花蛇舌草的成分并获取靶点信息,用Cytoscape 3.8.0软件对白花蛇舌草-大肠腺瘤可视化构图,并构建蛋白质相互作用网络。对白花蛇舌草-大肠腺瘤作用靶点进行GO富集分析、蛋白质相互作用网络、KEGG通路富集分析。结果:白花蛇舌草防治大肠腺瘤的作用机制中,可能主要以熊果酸、槲皮素成分为主作用腺瘤,通过EGFR、GRB2、MYC、NTRK1、TP53等靶点参与凋亡信号通路、细胞毒性作用、细胞因子介导的信号通路等生物过程,和激酶结合、转录因子结合、蛋白激酶活性、激酶调节活性等生物功能有关,包含转录因子复合物、Bcl-2家族蛋白、囊泡腔、细胞周期素依赖性蛋白激酶全酶复合物等分子组分。主要通过癌症通路中PI3K-Akt信号通路、MAPK信号通路、癌症中的蛋白多糖等多条通路。结论:在预测白花蛇舌草防治大肠腺潜在机制中,多个成分、靶点、通路作用于疾病,可能对大肠癌发挥预防作用,为进一步实验研究及临床干预早期癌变提供理论基础和参考。
  • 加载中
  • [1]

    张晓翠.白花蛇舌草的研究概况[J].时珍国药研究,1998,9(1):92-93.

    [2]

    南京中医药大学,赵国平,戴慎等.中药大辞典[M].上海:上海科学技术出版社,2006.

    [3]

    Qari YA.Clinicopathological characterization of colonic polyps[J].Nigerian J Clin Pract,2020,23(8):1048-1053.

    [4]

    Kim M,Vogtmann E,Ahlquist DA,et al.Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis[J].mBio,2020,11(1):e03186-19.

    [5]

    Zhao XX,Liu MH,Wang RL,et al.Effect of Gender and Age on the Correlation between Helicobacter pylori and Colorectal Adenomatous Polyps in a Chinese Urban Population:A Single Center Study[J].Gastroenterol Res Pract,2020,2020:8596038.

    [6]

    Ze EY,Kim BJ,Jun DH,et al.The Fatty Liver Index:A Simple and Accurate Predictor of Colorectal Adenoma in an Average-Risk Population[J].Dis Colon Rectum,2018,61(1):36-42.

    [7]

    张荣,林辉.2015年内镜下结肠直肠息肉切除术相关指南与共识解读[J].世界临床药物,2015,36(12):814-819.

    [8]

    Shi X,Yang Z,Wu Q,et al.Colorectal adenoma recurrence rates among post-polypectomy patients in the placebo-controlled groups of randomized clinical trials:a meta-analysis[J].Oncotarget,2017,8(37):62371-62381.

    [9]

    Snover DC.Update on the serrated pathway to colorectal carcinoma[J].Human Pathol,2011,42(1):1-10.

    [10]

    Nguyen LH,Goel A,Chung DC.Pathways of Colorectal Carcinogenesis[J].Gastroenterology,2020,158(2):291-302.

    [11]

    邱静,钱素婷,曹泽鹏,等.大肠湿热型结直肠腺瘤肠道菌群分布规律研究[J].中国中西医结合消化杂志,2021,29(3):187-192.

    [12]

    Zhou Q,Chen YG,Xiao J,et al.Traditional Chinese medicine(Xiaoai Jiedu Decoction)as an adjuvant treatment for prevention new colorectal adenomatous polyp occurrence in post-polypectomy:Study protocol for a randomized controlled trial[J].Medicine(Baltimore),2019,98(31):e16680.

    [13]

    郭秀清.中西医结合治疗大肠多发息肉临床研究[J].中国保健营养,2016,26(8):108-109.

    [14]

    张北平.一种防治大肠息肉的中药组合物:中国,CN201610117536.0[P].2019-10-01.

    [15]

    金健,张相安,郭海霞,等.张东岳教授运用消息灵方治疗大肠息肉经验[J].中医研究,2020,33(5):39-41.

    [16]

    王少墨,王秀薇,姚怡,等.王庆其治疗大肠息肉经验[J].中医杂志,2016,57(15):1278-1280.

    [17]

    Zhang P,Zhang B,Gu J,et al.The Study of the Effect of Hedyotis diffusa on the Proliferation and the Apoptosis of the Cervical Tumor in Nude Mouse Model[J].Cell Biochemistry Biophy,2015,72(3):783-789.

    [18]

    Lin L,Cheng K,He Z,et al.A polysaccharide from Hedyotis diffusa interrupts metastatic potential of lung adenocarcinoma A549 cells by inhibiting EMT via EGFR/Akt/ERK signaling pathways[J].Intern J Boil Macromolecul,2019,129:706-714.

    [19]

    Jia X,Wen Z,Sun Q,et al.Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway[J].J Balkan Union Oncol,2019,24(5):1985-1991.

    [20]

    Asati V,Mahapatra DK,Bharti SK.PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents:Structural and pharmacological perspectives[J].Eur J Med Chemistry,2016,109:314-341.

    [21]

    Sun Y,Liu WZ,Liu T,et al.Signaling pathway of MAPK/ERK in cell proliferation,differentiation,migration,senescence and apoptosis[J].J Receptor Signal Transduction Res,2015,35(6):600-604.

    [22]

    Fang JY,Richardson BC.The MAPK signalling pathways and colorectal cancer[J].Lancet Oncol,2005,6(5):322-327.

    [23]

    Rauf A,Imran M,Khan IA,et al.Anticancer potential of quercetin:A comprehensive review[J].Phytother Res,2018,32(11):2109-2130.

    [24]

    Chan EWC,Soon CY,Tan JBL,et al.Ursolic acid:An overview on its cytotoxic activities against breast and colorectal cancer cells[J].J Integrate Med,2019,17(3):155-160.

    [25]

    Nouri Z,Fakhri S,Nouri K,et al.Targeting Multiple Signaling Pathways in Cancer:The Rutin Therapeutic Approach[J].Cancers,2020,12(8):2276.

    [26]

    He J,Lu X,Wei T,et al.Asperuloside and Asperulosidic Acid Exert an Anti-Inflammatory Effect via Suppression of the NF-κB and MAPK Signaling Pathways in LPS-Induced RAW 264.7 Macrophages[J].Intern J Molecul,2018,19(7):2027.

    [27]

    Wang C,Xin P,Wang Y,et al.Iridoids and sfingolipids from Hedyotis diffusa[J].Fitoterapia,2018,124:152-159.

    [28]

    Li H,Lai Z,Yang H,et al.Hedyotis diffusa Willd.inhibits VEGFCmediated lymphangiogenesis in colorectal cancer via multiple signaling pathways[J].Oncol Rep,2019,42(3):1225-1236.

  • 加载中
计量
  • 文章访问数:  148
  • PDF下载数:  43
  • 施引文献:  0
出版历程
收稿日期:  2020-09-14

目录